Psyllium Satiety Randomized Trial: What the Evidence Says

Quick Answer

Psyllium Satiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• As a result of increased viscosity, bile cannot be absorbed effectively and is excreted in the feces, causing a decrease in the bile acid pool, stimulating hepatocytes to produce LDL cholesterol receptors and increase their numbers. [Günal Ahmet Murat (2025); evidence level 2]
• The United States Food and Drug Administration (FDA) has reported that adding over 7 g of psyllium to a diet low in saturated fat and cholesterol may reduce the risk of coronary heart disease (FDA ). [Günal Ahmet Murat (2025); evidence level 2]
• In particular, it may be effective in the management of conditions such as hypertension, diabetes, and liver disease, alongside other potential health benefits, such as its ability to support gastrointestinal health, cardiovascular risk reduction, and metabolic control. [Sanlier Nevin (2026); evidence level 4]
• Studies also emphasize its various metabolic and hepatoprotective effects, including the modulation of bile acid metabolism and the activation of pathways associated with the farnesoid X receptor. [Sanlier Nevin (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For psyllium satiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Günal Ahmet Murat (2025). Enrichment of Hamburger Meatballs With Psyllium: Effects on Postprandial Lipidemia, Glycemia, Appetite, and Food Intake in a Triple‐Blind Randomized Controlled Crossover Trial. DOI: 10.1002/fsn3.71066. PMCID: PMC12509172. PMID: 41078451. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12509172/
• Sanlier Nevin (2026). From Husks and Seeds to Health: an Inevitable Outcome Rather than a Fluke. DOI: 10.1007/s13668-025-00722-4. PMCID: PMC12935724. PMID: 41741921. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935724/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.